After obtaining U.S. and European approvals this summer, Enable Injections has claimed its first regulatory green light in Japan for its enFuse wearable drug delivery technology.
Tufts-led team pursues promising new approach to preventing and fighting the bacterium that causes the tick-borne illness
Solventum (NYSE: SOLV) has acquired an FDA clearance for a new combination of two of its active wound care approaches, which the company said will help streamline the healing process.
The Teleflex (NYSE: TFX) Freesolve RMS (resorbable magnesium scaffold) has won FDA Breakthrough Device designation for percutaneous coronary intervention (PCI).